Drawing for DCPRIME

USPTO serial 85263336

DCPRIME

Reviewed by CopyMark Law Group

Reg. 4137721Status 710
Filing date
Status date
Registration date
May 8, 2012
Examiner
COWARD, KATHRYN E
Law office
TMO LAW OFFICE 115

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with DCPRIME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer C. Debrow

Jennifer C. Debrow Lathrop GPM LLP500 IDS Center, 80 South 8th StreetMinneapolis, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Cancer vaccines; vaccines including therapeutic vaccines; pharmaceutical and biomedical preparations for the treatment of cancer; biological preparations, namely, medical carriers for antigens for the treatment of cancer; biological preparations for the treatment of cancerSECTION 8 - CANCELLED—
042Scientific and biomedical clinical studies and research; development of vaccines, therapeutic vaccines, cancer vaccines, biological preparations, namely, medical carriers for antigens, biomedical and pharmaceutical preparations and biological preparations for medical purposesSECTION 8 - CANCELLED—
044Medical services; pharmaceutical and biomedical advisorySECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 6, 2023C8.TCANCELLED SEC. 8 (10-YR)—
Mar 2, 2023PR89POST REGISTRATION ACTION MAILED - SEC. 8 & 9—
Jan 4, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 3, 2023PR89POST REGISTRATION ACTION MAILED - SEC. 8 & 9—
Nov 3, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 3, 2022E89RTEAS SECTION 8 & 9 RECEIVED—
May 8, 2021REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
May 7, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 7, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 10, 2019NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Apr 10, 2019C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Apr 3, 2019EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Feb 27, 2019PR23POST REGISTRATION ACTION MAILED - SEC. 8 & 15—
Jan 25, 2019EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jul 25, 2018PR23POST REGISTRATION ACTION MAILED - SEC. 8 & 15—
Jul 23, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 11, 2018E815TEAS SECTION 8 & 15 RECEIVED—
Jun 18, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 18, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 8, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 21, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 1, 2012NPUBNOTICE OF PUBLICATION—
Jan 13, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 13, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 11, 2012DMCCDATA MODIFICATION COMPLETED—
Jan 11, 2012CNEAEXAMINERS AMENDMENT MAILED—
Jan 10, 2012XAECEXAMINER'S AMENDMENT ENTERED—
Jan 10, 2012CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 3, 2012MAILPAPER RECEIVED—
Dec 19, 2011ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 19, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 15, 2011ALIEASSIGNED TO LIE—
Dec 12, 2011MAILPAPER RECEIVED—
Jun 10, 2011CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 10, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 10, 2011DOCKASSIGNED TO EXAMINER—
Mar 29, 2011TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Mar 29, 2011PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Mar 17, 2011MPMKNOTICE OF PSEUDO MARK MAILED—
Mar 16, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 14, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance